Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266734 · ClinicalTrials.gov registry record · NA
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
A NA study, sponsored by Rapid Pathogen Screening.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT00266734 is a NA study that has completed, run by Rapid Pathogen Screening. The registered enrollment target is 186 participants.
The verdict
NCT00266734, a NA study, has completed, sponsored by Rapid Pathogen Screening.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis
Interventions
- DEVICE RPS Adeno Detector
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00266734
The ClinicalTrials.gov registry entry for NCT00266734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rapid Pathogen Screening, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RPS Adeno Detector is the first listed.
NCT00266734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00266734 about?
NCT00266734 is a clinical study titled "Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears". To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis
What is the current status of trial NCT00266734?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2004-12. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00266734?
The interventions under investigation include: RPS Adeno Detector (DEVICE).
Who is sponsoring clinical trial NCT00266734?
This trial is sponsored by Rapid Pathogen Screening, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.